Skip to main content

Table 2 Prevalence of all 16 combination types according to age-groups and sex

From: Age- and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factor combinations of the metabolic syndrome - A cross-sectional study

Combinations of MetS 18-30 years
% (95%-CI)1
31-45 years
% (95%-CI)
46-60 years
% (95%-CI)
61-75 years
% (95%-CI)
76-99 years
% (95%-CI)
WC TG HDL BP GL           
Combinations more frequent in the young Men Women Men Women Men Women Men Women Men Women
WC TG HDL BP - 10.9
(4.5-21.3)
13.3
(6.8-22.5)
9.0
(6.1-12.7)
10.5
(7.6-14.0)
3.3
(2.2-4.6)
7.4
(5.9-9.2)
1.9
(1.1-2.9)
4.1
(3.1-5.4)
1.8
(0.5-4.4)
3.5
(2.0-5.6)
WC TG HDL - - 0 9.6
(4.3-18.1)
3.7
(1.9-6.4)
7.6
(5.2-10.8)
1.5
(0.8-2.5)
2.7
(1.8-3.9)
0.3
(0.1-0.9)
1.0
(0.5-1.7)
0 0.7
(0.1-1.9)
WC TG - BP - 37.5
(25.7-50.5)
13.3
(6.8-22.5)
22.4
(17.9-27.3)
12.6
(9.4-16.4)
16.5
(14.2-19.0)
14.7
(12.6-17.0)
10.0
(8.2-12.0)
13.0
(11.2-15.0)
7.5
(4.4-11.7)
11.1
(8.4-14.4)
WC - HDL BP - 12.5
(5.6-23.2)
39.8
(29.2-51.1)
6.5
(4.1-9.8)
27.6
(23.1-32.3)
2.0
(1.2-3.1)
9.7
(8.0-11.7)
2.5
(1.6-3.7)
4.3
(3.3-5.6)
3.5
(1.5-6.8)
3.7
(2.2-5.9)
- TG HDL BP - 18.8
(10.1-30.5)
2.4
(0.3-8.4)
10.3
(7.2-14.1)
5.2
(3.2-8.0)
2.9
(1.9-4.1)
1.9
(1.1-2.9)
1.3
(0.7-2.2)
1.9
(1.2-2.8)
2.2
(0.7-5.0)
1.1
(0.4-2.5)
Combinations more frequent in the elderly
WC - - BP GL 1.6
(0.0-8.4)
4.8
(1.3-11.9)
14.6
(10.9-18.9)
10.8
(7.8-14.3)
25.9
(23.1-28.8)
27.0
(24.3-29.8)
33.8
(30.9-36.9)
33.7
(31.1-36.5)
35.5
(29.3-42.1)
32.7
(28.4-37.2)
- TG - BP GL 0
-
0
-
8.7
(5.9-12.3)
0.8
(0.2-2.3)
10.3
(8.5-12.5)
2.6
(1.7-3.8)
10.2
(8.4-12.3)
2.7
(1.9-3.8)
10.1
(6.5-14.8)
7.2
(5.0-10.0)
WC TG - - GL 0
-
1.2
(0.0-6.5)
1.6
(0.5-3.6)
1.6
(0.6-3.4)
4.4
(3.2-6.0)
2.0
(1.3-3.1)
3.1
(2.1-4.4)
3.1
(2.2-4.2)
2.6
(1.0-5.6)
2.2
(1.1-4.0)
WC TG HDL BP GL 3.1
(0.4-10.8)
6.0
(2.0-13.5)
3.7
(1.9-6.4)
5.2
(3.2-8.0)
7.1
(5.5-8.9)
8.4
(6.8-10.2)
6.3
(4.9-8.0)
8.7
(7.2-10.5)
4.8
(2.4-8.5)
9.6
(7.1-12.7)
WC TG HDL - GL 0
-
0
-
2.2
(0.9-4.4)
3.4
(1.8-5.8)
1.3
(0.7-2.2)
2.6
(1.7-3.8)
2.1
(1.3-3.2)
1.8
(1.1-2.7)
1.3
(0.3-3.8)
1.3
(0.5-2.8)
WC TG - BP GL 4.7
(1.0-13.1)
1.2
(0.0-6.5)
9.6
(6.6-13.4)
3.9
(2.2-6.4)
16.4
(14.1-18.9)
12.3
(10.3-14.4)
20.0
(17.6-22.6)
15.7
(13.7-17.9)
18.9
(14.0-24.6)
12.9
(9.9-16.3)
WC - HDL BP GL 1.6
(0.0-8.4)
6.0
(2.0-13.5)
1.2
(0.3-3.2)
6.3
(4.1-9.2)
2.3
(1.5-3.5)
5.3
(4.0-6.8)
3.8
(2.7-5.2)
6.0
(4.8-7.5)
2.6
(1.0-5.6)
6.3
(4.3-9.0)
- TG HDL BP GL 1.6
(0.0-8.4)
0
-
3.4
(1.7-6.0)
0.5
(0.1-1.9)
2.6
(1.7-3.9)
0.7
(0.3-1.4)
2.4
(1.5-3.5)
1.6
(1.0-2.5)
3.1
(1.2-6.2)
3.3
(1.8-5.3)
- - HDL BP GL 3.1
(0.4-10.8)
1.2
(0.0-6.5)
0.6
(0.1-2.2)
1.0
(0.3-2.7)
1.4
(0.7-2.3)
0.7
(0.3-1.4)
0.9
(0.4-1.7)
0.8
(0.4-1.5)
4.4
(2.1-7.9)
3.5
(2.0-5.6)
WC - HDL - GL 1.6
(0.0-8.4)
1.2
(0.0-6.5)
1.6
(0.5-3.6)
1.8
(0.7-3.8)
1.1
(0.5-1.9)
1.4
(0.8-2.3)
0.9
(0.4-1.7)
1.2
(0.7-2.0)
0.4
(0.0-2.4)
0.7
(0.1-1.9)
- TG HDL - GL 3.1
(0.4-10.8)
0
-
0.9
(0.2-2.7)
1.0
(0.3-2.7)
1.2
(0.6-2.1)
0.7
(0.3-1.4)
0.6
(0.2-1.3)
0.2
(0.1-0.7)
1.3
(0.3-3.8)
0.4
(0.1-1.6)
  1. WC, waist circumference; TG- triglycerides; HDL, High Density Lipoproteins; elevated BP, blood pressure; GL, elevated blood glucose. For cut points used see methods; 95%-CI, 95% confidence intervals; the higher prevalence in comparing men and women is in bold;
  2. 1Percent of MetS prevalence in specific group defined by age and gender